Polydatin alleviates <scp>DSS‐</scp> and <scp>TNBS</scp> ‐induced colitis by suppressing Th17 cell differentiation via directly inhibiting <scp>STAT3</scp>-Reference-Cited by-同舟云学术

Polydatin alleviates DSS‐ and TNBS ‐induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3

Published:2022-06-29 Issue:9 Volume:36 Page:3662-3671
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Liu Yao‐Jun¹,Xu Wei‐Heng²,Fan Li‐Ming¹,Zhang Yu‐Qin¹,Xu Wen¹,Chen Ya‐Ping¹,Chen Lin‐Lin²,Chen Li¹,Xu Wei¹,Wang Yan²,Chu Ke‐Dan¹,Zhang Jun‐Ping¹²^ORCID

Affiliation:

1. College of Pharmacy Fujian University of Traditional Chinese Medicine Fuzhou P.R. China

2. College of Pharmacy Second Military Medical University Shanghai P.R. China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7533

Reference41 articles.

1. Anti-TNF Therapy and Radiation Exposure in Crohnʼs Disease

2. Epidemiology and risk factors for IBD

3. Inflammatory bowel disease: cause and immunobiology

4. Inflammatory bowel disease: clinical aspects and established and evolving therapies

5. gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways;Marine Drugs;2024-09-09

2. Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation;Chemico-Biological Interactions;2024-08

3. Polyvinylpyrrolidone-Polydatin nanoparticles protect against oxaliplatin induced intestinal toxicity in vitro and in vivo;Food and Chemical Toxicology;2024-02

4. Traditional herbs: mechanisms to combat cellular senescence;Aging;2023-12-05

5. Citropten alleviates acute and recurrent colitis via blockage of NF-κB and JAK/STAT3 pathways;International Immunopharmacology;2023-12